Cytosorbents Corp expected to post a loss of 90 cents a share - Earnings Preview

What happened

CytoSorbents Corp is expected to report a 4.5% rise in quarterly revenue to $9.915 million, up from $9.49 million a year earlier, when it reports results on November 12 for the period ending September 30, 2026. Analysts expect a loss of 90 cents a share.

Confirmed

Global impact / market context

Revenue growth alongside a expected loss of 90 cents a share shows the company is selling more but still not turning a profit. Investors will compare the actual loss with that estimate to judge whether costs are coming under control.

Analyst inference

Analysts rate the shares a buy, split between one buy and one hold, with no sells. The median 12-month price target of $15.00 sits about 240.9% above the last closing price of $4.40, suggesting analysts see large potential upside.

Analyst inference

What to watch

1. Watch whether reported revenue meets the $9.915 million mean estimate from two analysts, a 4.5% increase from $9.49 million a year ago, when results are released on November 12. Confirmed
2. Watch whether the company narrows its loss toward the expected 90 cents a share, since a wider loss would mean costs are rising faster than revenue despite the sales growth. Proposed
3. Watch whether the gap between the $15.00 median price target and the $4.40 closing price holds, since a weak report could lead analysts to cut targets and ratings. Analyst inference

Evidence

• Original source link unavailable